(Example: 154 lbs / 2.2 = 70kg)
Authors are legally required to adhere to the Declaration of Helsinki when interacting with donors and to explicitly mention the name of the granting body and approval date, and number
Dosage: 60 to 100 mcg per day Frequency: Once daily or split into two doses Administration: Subcutaneous or intramuscular Cycle length: 4 to 6 weeks maximum Time off: Longer than time on Important: IGF-1 LR3 dosage should not exceed 100 mcg per day according to most research protocols
Pharmaceutical-grade manufacturing with batch-level documentation available for qualified buyers
Dentico, P., Volpe, A., Buongiorno, R., Grattagliano, I., Altomare, E., Tantimonaco, G., Scotto, G., Sacco, R., & Schiraldi, O